The surgical robotics maker posts better-than-expected quarterly earnings as it begins rollout of cardiac procedures.

Intuitive Surgical's stock is prone to drawdowns, and January could be an opening for long-term growth investors.

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Intuitive Surgical is a first-to-market leader in the field of surgical robotics. Medtronic is making headway with its own robot-assisted surgical system. Teradyne has a growing robotics segment and a ...

Intuitive Surgical is a pure-play leader in robotic-assisted soft-tissue surgery. The company’s da Vinci platform is its foundational asset, supporting procedures across urology, gynecology, general ...

Intuitive Surgical Inc (NASDAQ: ISRG) reported its fourth-quarter results in line with its preannouncement and announced a "measured" guidance for 2026, according to BTIG. The Intuitive Surgical ...

Global robotics industry may grow to $218 billion by 2030, suggesting robust expansion. Nvidia, a leader in AI and robotics, empowers robust computational processes for robotics. Intuitive Surgical's ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force Feedback instruments.

Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.